Abgenix to Host Conference Call on Fourth Quarter and Full Year 2004 Financial Results
Tuesday February 15, 5:56 pm ET
FREMONT, Calif., Feb. 15 /PRNewswire-FirstCall/ -- Abgenix, Inc. (Nasdaq: ABGX - News) will hold a conference call on Tuesday, February 22, 2004 at 1:30 p.m. PT, 4:30 p.m. ET, to discuss fourth quarter and year-end 2004 financial results. The call will be hosted by Bill Ringo, president and chief executive officer of Abgenix.
ADVERTISEMENT
To participate in the teleconference, please call 800-638-4817 fifteen minutes before the conference begins. International callers should dial 617-614-3943. Participant pass code is 30874380. The call will also be webcast live at www.abgenix.com. A replay of the call will be available until March 8, 2005 on the company's website or by dialing 888-286-8010. International callers should dial 617-801-6888. Replay participant code is 61046372.
About Abgenix
Abgenix is a biopharmaceutical company focused on the discovery, development and manufacturing of human therapeutic antibodies. The company's antibody development platform includes a leading technology and state-of-the- art manufacturing capabilities that enable the rapid generation, selection and production of high affinity, fully human antibody product candidates to a variety of disease targets. Abgenix leverages its leadership position in human antibody technology to build a diversified product portfolio through the establishment of collaborations with multiple pharmaceutical and biotechnology companies. For more information on Abgenix, visit the company's website at www.abgenix.com. |
